Cambrex, a global contract development and manufacturing organization (CDMO) providing drug substance, drug product, and analytical services, has entered into a definitive agreement to acquire Snapdragon Chemistry, a U.S.-based provider of chemical process development services to a broad range of emerging and established biopharma customers.   Snapdragon specializes in active pharmaceutical ingredient (API) batch and continuous flow process development, using state-of-the-art automation techno...